Skip to main content

Table 2 Changes in the levels of GPX, IL-6, IL-8 and IL-10 over time period in study patients

From: The effect of parenteral selenium on outcomes of mechanically ventilated patients following sepsis: a prospective randomized clinical trial

Biomarker (pg/mL) Selenium group Control group P value
Glutathione peroxidase (U/mL)
 GPX on day 0 0.185 ± 0.3 0.19 ± 0.3 0.90
 GPX on day 3 0.52 ± 0.5 0.17 ± 0.2 0.02
 GPX on day 7 0.55 ± 0.5 0.24 ± 0.3 0.032
 GPX on day 10 0.62 ± 0.2 0.33 ± 0.1 0.048
 GPX on day 14 1.1 ± 1 0.89 ± 1 0.70
IL-6 (pg/mL)
 Day 0 43.3 ± 34 37.8 ± 35.6 0.61
 Day 3 25 ± 28 32.7 ± 33.3 0.42
 Day 7 21.6 ± 27.6 18.6 ± 24 0.75
 Day 10 32.5 ± 31.8 29.8 ± 33.5 0.82
 Day 14 30.9 ± 33.8 31.4 ± 30 0.97
IL-8 (pg/mL)
 Day 0 4.1 ± 5 4 ± 5.0 0.95
 Day 3 5.7 ± 7.5 4.5 ± 6.8 0.58
 Day 7 5.8 ± 8 5 ± 6.8.0 0.78
 Day 10 4.8 ± 8 5.8 ± 5 0.73
 Day 14 6.1 ± 8 6.1 ± 9 0.99
IL-10 (pg/mL)
 Day 0 4.6 ± 3 3.6 ± 2 0.26
 Day 3 4.6 ± 3.7 4.2 ± 4.5 0.76
 Day 7 3.8 ± 2.8 5.8 ± 5.7 0.21
 Day 10 3.8 ± 3.5 6.2 ± 6 0.23
 Day 14 3.9 ± 4.6 6 ± 4.6 0.26
  1. Data presented in mean ± SD
  2. GPX glutathione peroxidase, IL-6 interleukin-6, IL-8 interleukin-8, IL-10 interleukin-10